Oxidative DNA Damage and Carcinogenesis

  • Ryszard Olinski
  • Marek Foksinski
  • Barbara Tudek
Part of the Molecular Biology Intelligence Unit book series (MBIU)


In living cells, there is a steady formation of DNA lesions. A substantial number of these lesions are formed by endogenous factors such as reactive oxygen species (ROS) that damage DNA on a continuous basis. Therefore, it is likely that ROS are the most important human carcinogens.

An involvement of oxidative DNA damage, particularly 8-hydroxy-7, 8-dihydroguanine (8-OHGua) in the origin and/or progression of cancer is reviewed. It is concluded that severe oxidative stress manifested as an altered level of 8-OHGua in cellular DNA as well as in urine of cancer patients may be a consequence of development of many types of cancer. Although at present it is impossible to answer directly the question concerning involvement of oxidative DNA damage in cancer etiology it is very likely that oxidative DNA base modifications may serve as a source of mutations that initiate carcinogenesis (i.e., they may be causal factors responsible for the process).

It should also be remembered that DNA damage, altered gene expression and mutations are required participants in the process of carcinogenesis. Although these events may be derived by different mechanisms a commonality is the involvement of oxidants in all these phenomena.


Lung Cancer Patient Repair Capacity Uterine Myoma Maximum Life Span Severe Oxidative Stress 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    DePinho RA. The age of cancer. Nature 2000; 408:248–254.PubMedCrossRefGoogle Scholar
  2. 2.
    Vanderkooi JM, Erecinska M, Silver IA. Oxygen in mammalian tissue: Methods of measurement and affinities of various reactions. Am J Physiol 1991; 260:C1131–C1150.PubMedGoogle Scholar
  3. 3.
    Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res 1992; 275:331–342.PubMedGoogle Scholar
  4. 4.
    Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990; 11:1447–1450.PubMedCrossRefGoogle Scholar
  5. 5.
    Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001; 477:7–21.PubMedGoogle Scholar
  6. 6.
    Cheng KC, Cahill DS, Kasai H et al. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J Biol Chem 1992; 267:166–172.PubMedGoogle Scholar
  7. 7.
    Levine RL, Yang IY, Hossain M et al. Mutagenesis induced by a single 1, N6-ethenodeoxyadenosine adduct in human cells. Cancer Res 2000; 60:4098–4104.PubMedGoogle Scholar
  8. 8.
    Moriya M, Pandya GA, Johnson F et al. Cellular response to exocyclic DNA adducts. IARC Sci Publ., 1999:263–270.Google Scholar
  9. 9.
    Speina E, Kierzek AM, Tudek B. Chemical rearrangement and repair pathways of 1,N6-ethenoadenine. Mutat Res 2003; 531:205–217.PubMedGoogle Scholar
  10. 10.
    Bartsch H, Barbin A, Marion MJ et al. Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metab Rev 1994; 26:349–371.PubMedCrossRefGoogle Scholar
  11. 11.
    Kowalczyk P, Ciesla JM, Komisarski M et al. Long-chain adducts of trans-4-hydroxy-2-nonenal to DNA bases cause recombination, base substitutions and frameshift mutations in M13 phage. Mutat Res 2004; 550:33–48.PubMedGoogle Scholar
  12. 12.
    Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994; 54:1890s–1894s.PubMedGoogle Scholar
  13. 13.
    Du MQ, Carmichael PL, Phillips DH. Induction of activating mutations in the human c-Ha-ras-1 proto-oncogene by oxygen free radicals. Mol Carcinogen 1994; 11:170–175.CrossRefGoogle Scholar
  14. 14.
    Yu D, Berlin JA, Penning TM et al. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem Res Toxicol 2002; 15:832–842.PubMedCrossRefGoogle Scholar
  15. 15.
    Hu W, Feng Z, Eveleigh J et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 2002; 23:1781–1789.PubMedCrossRefGoogle Scholar
  16. 16.
    Olinski R, Zastawny T, Budzbon J et al. DNA base modifications in chromatin of human cancerous tissues. FEBS Lett 1992; 309:193–198.PubMedCrossRefGoogle Scholar
  17. 17.
    Malins DC, Holmes EH, Polissar NL et al. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993; 71:3036–3043.PubMedCrossRefGoogle Scholar
  18. 18.
    Okamoto K, Toyokuni S, Uchida K et al. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 1994; 58:825–829.PubMedCrossRefGoogle Scholar
  19. 19.
    Jaruga P, Zastawny TH, Skokowski J et al. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 1994; 341:59–61.PubMedCrossRefGoogle Scholar
  20. 20.
    Kasprzak KS, Jaruga P, Zastawny TH et al. Oxidative DNA base damage and its repair in kidneys and livers of nickel(II)-treated male F344 rats. Carcinogenesis 1997; 18:271–277.PubMedCrossRefGoogle Scholar
  21. 21.
    Foksinski M, Kotzbach R, Szymanski W et al. The level of typical biomarker of oxidative stress 8-hydroxy-2′-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor. Free Radic Biol Med 2000; 29:597–601.PubMedCrossRefGoogle Scholar
  22. 22.
    Schwartz LB, Diamond MP, Schwartz PE. Leiomyosarcomas: Clinical presentation. Am J Obstet Gynecol 1993; 168:180–183.PubMedGoogle Scholar
  23. 23.
    Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525–532.PubMedGoogle Scholar
  24. 24.
    Ionov Y, Peinado MA, Malkhosyan S et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363:558–561.PubMedCrossRefGoogle Scholar
  25. 25.
    Rozalski R, Gackowski D, Roszkowski K et al. The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects. Cancer Epidemiol Biomarkers Prev 2002; 11:1072–1075.PubMedGoogle Scholar
  26. 26.
    Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 1991; 51:5430–5432.PubMedGoogle Scholar
  27. 27.
    Toyokuni S, Okamoto K, Yodoi J et al. Persistent oxidative stress in cancer. FEBS Lett 1995; 358:1–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Cooke MS, Evans MD, Herbert KE et al. Urinary 8-oxo-2′-deoxyguanosine—source, significance and supplements. Free Radical Res 2000; 32:381–397.CrossRefGoogle Scholar
  29. 29.
    Loft S, Poulsen HE. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim Pol 1998; 45:133–144.PubMedGoogle Scholar
  30. 30.
    Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res 2001; 61:4756–4760.PubMedGoogle Scholar
  31. 31.
    Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51:794–798.PubMedGoogle Scholar
  32. 32.
    De Vita Jr VT, Hellman S, Rosenberg SA. Cancer. Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott Wiliams and Wilkins, 2001.Google Scholar
  33. 33.
    Dizdaroglu M, Olinski R, Doroshow JH et al. Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes. Cancer Res 1993; 53:1269–1272.PubMedGoogle Scholar
  34. 34.
    Franks LM, Teich NM. Introduction to the cellular and molecular biology of cancer. 3rd ed. Oxford, New York, Tokyo: Oxford University Press, 1997.Google Scholar
  35. 35.
    Ohba M, Shibanuma M, Kuroki T et al. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 1994; 126:1079–1088.PubMedCrossRefGoogle Scholar
  36. 36.
    Kayanoki Y, Fujii J, Suzuki K et al. Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. J Biol Chem 1994; 269:15488–15492.PubMedGoogle Scholar
  37. 37.
    Peddie CM, Wolf CR, McLellan LI et al. Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentration. Br J Haematol 1997; 99:625–631.PubMedCrossRefGoogle Scholar
  38. 38.
    Hazra TK, Izumi T, Venkataraman R et al. Characterization of a novel 8-oxoguanine-DNA glycosylase activity in Escherichia coli and identification of the enzyme as endonuclease VIII. J Biol Chem 2000; 275:27762–27767.PubMedGoogle Scholar
  39. 39.
    Radicella JP, Dherin C, Desmaze C et al. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1997; 94:8010–8015.PubMedCrossRefGoogle Scholar
  40. 40.
    Hazra TK, Izumi T, Maidt L et al. The presence of two distinct 8-oxoguanine repair enzymes in human cells: Their potential complementary roles in preventing mutation. Nucleic Acids Res 1998; 26:5116–5122.PubMedCrossRefGoogle Scholar
  41. 41.
    Hazra TK, Hill JW, Izumi T et al. Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions. Prog Nucleic Acid Res Mol Biol 2001; 68:193–205.PubMedCrossRefGoogle Scholar
  42. 42.
    Hazra TK, Izumi T, Boldogh I et al. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc Natl Acad Sci USA 2002; 99:3523–3528.PubMedCrossRefGoogle Scholar
  43. 43.
    Dou H, Mitra S, Hazra TK. Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. J Biol Chem 2003; 278:49679–49684.PubMedCrossRefGoogle Scholar
  44. 44.
    Rajaee-Behbahani N, Schmezer P, Risch A et al. Altered DNA repair capacity and bleomycin sensitivity as risk markers for nonsmall cell lung cancer. Int J Cancer 2001; 95:86–91.PubMedCrossRefGoogle Scholar
  45. 45.
    Wikman H, Risch A, Klimek F et al. hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population. Int J Cancer 2000; 88:932–937.PubMedCrossRefGoogle Scholar
  46. 46.
    Hardie LJ, Briggs JA, Davidson LA et al. The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis 2000; 21:167–172.PubMedCrossRefGoogle Scholar
  47. 47.
    Butkiewicz D, Rusin M, Enewold L et al. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001; 22:593–597.PubMedCrossRefGoogle Scholar
  48. 48.
    Le Marchand L, Donlon T, Lum-Jones A et al. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11:409–412.PubMedGoogle Scholar
  49. 49.
    Kohno T, Shinmura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16:3219–3225.PubMedCrossRefGoogle Scholar
  50. 50.
    Sugimura H, Kohno T, Wakai K et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1999; 8:669–674.PubMedGoogle Scholar
  51. 51.
    Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11:1513–1530.PubMedGoogle Scholar
  52. 52.
    Hart RW, Setlow RB. Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species. Proc Natl Acad Sci USA 1974; 71:2169–2173.PubMedCrossRefGoogle Scholar
  53. 53.
    Gackowski D, Speina E, Zielinska M et al. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 2003; 63:4899–4902.PubMedGoogle Scholar
  54. 54.
    Paz-Elizur T, Krupsky M, Blumenstein S et al. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003; 95:1312–1319.PubMedGoogle Scholar
  55. 55.
    Sakumi K, Tominaga Y, Furuchi M et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 2003; 63:902–905.PubMedGoogle Scholar
  56. 56.
    Speina E, Arczewska KD, Gackowski D et al. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of nonsmall-cell lung cancer patients. J Natl Cancer Inst 2005; 97:384–395.PubMedGoogle Scholar
  57. 57.
    Kennedy CH, Pass HI, Mitchell JB. Expression of human MutT homologue (hMTH1) protein in primary nonsmall-cell lung carcinomas and histologically normal surrounding tissue. Free Radical Biol Med 2003; 34:1447–1457.CrossRefGoogle Scholar
  58. 58.
    Hill JW, Hazra TK, Izumi T et al. Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: Potential coordination of the initial steps in base excision repair. Nucleic Acids Res 2001; 29:430–438.PubMedCrossRefGoogle Scholar
  59. 59.
    Russo MT, Blasi MF, Chiera F et al. The oxidized deoxynucleoside triphosphate pool is a significant contributor to genetic instability in mismatch repair-deficient cells. Mol Cell Biol 2004; 24:465–474.PubMedCrossRefGoogle Scholar
  60. 60.
    Kennedy CH, Cueto R, Belinsky SA et al. Overexpression of hMTH1 mRNA: A molecular marker of oxidative stress in lung cancer cells. FEBS Lett 1998; 429:17–20.PubMedCrossRefGoogle Scholar
  61. 61.
    Bialkowski K, Bialkowska A, Anderson LM et al. Higher activity of 8-oxo-2′-deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) coincides with lower background levels of 8-oxo-2′-deoxyguanosine in DNA of fetal compared with maternal mouse organs. Free Radical Biol Med 1999; 27:90–94.CrossRefGoogle Scholar
  62. 62.
    Chevillard S, Radicella JP, Levalois C et al. Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 1998; 16:3083–3086.PubMedCrossRefGoogle Scholar
  63. 63.
    Fan CY, Liu KL, Huang HY et al. Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest 2001; 81:1429–1438.PubMedGoogle Scholar
  64. 64.
    Marsin S, Vidal AE, Sossou M et al. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem 2003; 278:44068–44074.PubMedCrossRefGoogle Scholar
  65. 65.
    Mokkapati SK, Wiederhold L, Hazra TK et al. Stimulation of DNA glycosylase activity of OGG1 by NEIL1: Functional collaboration between two human DNA glycosylases. Biochemistry 2004; 43:11596–11604.PubMedCrossRefGoogle Scholar
  66. 66.
    Habib SL, Phan MN, Patel SK et al. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. Carcinogenesis 2003; 24:573–582.PubMedCrossRefGoogle Scholar
  67. 67.
    Jaiswal M, LaRusso NF, Nishioka N et al. Human Oggl, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res 2001; 61:6388–6393.PubMedGoogle Scholar
  68. 68.
    Graziewicz M, Wink DA, Laval F. Nitric oxide inhibits DNA ligase activity: Potential mechanisms for NO-mediated DNA damage. Carcinogenesis 1996; 17:2501–2505.PubMedCrossRefGoogle Scholar
  69. 69.
    Wink DA, Laval J. The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 1994; 15:2125–2129.PubMedCrossRefGoogle Scholar
  70. 70.
    Laval F, Wink DA. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis 1994; 15:443–447.PubMedCrossRefGoogle Scholar
  71. 71.
    Fujimoto H, Ando Y, Yamashita T et al. Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res 1997; 88:1190–1198.PubMedGoogle Scholar
  72. 72.
    Ambs S, Bennett WP, Merriam WG et al. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer 1998; 78:233–239.PubMedCrossRefGoogle Scholar
  73. 73.
    Speina E, Zielinska M, Barbin A et al. Decreased repair activities of 1,N(6)-ethenoadenine and 3,N(4)-ethenocytosine in lung adenocarcinoma patients. Cancer Res 2003; 63:4351–4357.PubMedGoogle Scholar
  74. 74.
    Saparbaev M, Kleibl K, Laval J. Escherichia coli, Saccharomyces cerevisiae, rat and human 3-methyladenine DNA glycosylases repair 1,N6-ethenoadenine when present in DNA. Nucleic Acids Res 1995; 23:3750–3755.PubMedCrossRefGoogle Scholar
  75. 75.
    Saparbaev M, Laval J. 3,N4-ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase. Proc Natl Acad Sci USA 1998; 95:8508–8513.PubMedCrossRefGoogle Scholar
  76. 76.
    Privezentzev CV, Saparbaev M, Laval J. The HAP1 protein stimulates the turnover of human mismatch-specific thymine-DNA-glycosylase to process 3,N(4)-ethenocytosine residues. Mutat Res 2001; 480–481:277–284.PubMedGoogle Scholar
  77. 77.
    Ischida T, Takashima R, Fukuyama R et al. New DNA polymorphisms of human MMH/OGG1 gene: Prevalence of one polymorphism among lung-adenocarcinoma patients in Japanese. Int J Cancer 1999; 80:18–21.CrossRefGoogle Scholar
  78. 78.
    Hasty P, Vijg J. Aging. Genomic priorities in aging. Science 2002; 296:1250–1251.PubMedCrossRefGoogle Scholar
  79. 79.
    Cutler RG. Antioxidants and aging. Am J Clin Nutr 1991; 53:373S–379S.PubMedGoogle Scholar
  80. 80.
    Adelman R, Saul RL, Ames BN. Oxidative damage to DNA: Relation to species metabolic rate and life span. Proc Natl Acad Sci USA 1988; 85:2706–2708.PubMedCrossRefGoogle Scholar
  81. 81.
    Wang D, Kreutzer DA, Essigmann JM. Mutagenicity and repair of oxidative DNA damage: Insights from studies using defined lesions. Mutat Res 1998; 400:99–115.PubMedGoogle Scholar
  82. 82.
    Bohr VA, Dianov GL. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 1999; 81:155–160.PubMedCrossRefGoogle Scholar
  83. 83.
    Foksinski M, Rozalski R, Guz J et al. Urinary excretion of DNA repair products correlates with metabolic rates as well as with maximum life spans of different mammalian species. Free Radical Biol Med 2004; 37:1449–1454.CrossRefGoogle Scholar
  84. 84.
    Helbock HJ, Beckman KB, Shigenaga MK et al. DNA oxidation matters: The HPLC-electrochemical derection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci USA 1998; 95:288–293.PubMedCrossRefGoogle Scholar
  85. 85.
    Hamilton ML, Guo Z, Fuller CD et al. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res 2001; 29:2117–2126.PubMedCrossRefGoogle Scholar
  86. 86.
    Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995; 92:5258–5265.PubMedCrossRefGoogle Scholar
  87. 87.
    Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860–867.PubMedCrossRefGoogle Scholar
  88. 88.
    Shen Z, Wu W, Hazen SL. Activated leukocytes oxidatively damage DNA, RNA, and the nucleoride pool through halide-dependent formation of hydroxyl radical. Biochemistry 2000; 39:5474–5482.PubMedCrossRefGoogle Scholar
  89. 89.
    D’Inca R, Cardin R, Benazzato L et al. Oxidative DNA damage in the mucosa of ulcerative colitis increases with diasease duration and dysplasia. Inflamm Bowel Dis 2004; 10:23–27.PubMedCrossRefGoogle Scholar
  90. 90.
    Baik SC, Youn HS, Chung MH et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996; 56:1279–1282.PubMedGoogle Scholar
  91. 91.
    Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001; 477:7–21.PubMedGoogle Scholar
  92. 92.
    Hino O, Kajino K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 1994; 37:133–135.PubMedGoogle Scholar
  93. 93.
    Moriya K, Nakagawa K, Santa T et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001; 61:4365–4370.PubMedGoogle Scholar
  94. 94.
    Shimoda R, Nagashima M, Sakamoto M et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994; 54:3171–3172.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2007

Authors and Affiliations

  • Ryszard Olinski
    • 1
  • Marek Foksinski
    • 1
  • Barbara Tudek
    • 2
  1. 1.Department of Clinical BiochemistryCollegium Medicum Nicolaus Copernicus UniversityBydgoszczPoland
  2. 2.Department of Molecular Biology Institute of Biochemistry and BiophysicsPolish Academy of SciencesWarsawPoland

Personalised recommendations